Dr. Griffith’s lab focuses on humanizing drug development by merging systems biology, tissue engineering, and organs on chips. The Liverchip technology she developed is used in academic and industry labs for modeling human liver biology in vitro, and she has recently extended this technology to model gut-liver and other multi-organ interactions, and to a model of sustained co-culture of the strict anaerobes in the gut microbiome with a healthy human colon mucosa. She is especially focused on using systems biology to delineate subgroups of endometriosis patients and to build microvascularized models of lesions to test new drug targets. She is a member of the National Academy of Engineering, the National Academy of Medicine, the American Academy of Arts and Sciences, and recipient of a MacArthur Foundation Fellowship. Dr. Griffith serves on the advisory board of the Society for Women’s Health Research and has served on the Advisory Committee to the Director of the NIH.
Aleksandar Rajkovic, UCSF
Kathryn G. Schubert, Society for Women's Health Research
Researchers have long been recognizing the uniqueness of women’s health and its substantial effect on clinical practice, acknowledging the increasing appreciation of the importance of multidisciplinary approaches to health and disease. In every organ system, there are diseases that are unique to women, more common in women than in men, or characterized by differences in disease course in women compared to men. This Track will focus on the following topics related to Women’s Health: